S-100 protein reactivity in synovial sarcomas - A potentially frequent diagnostic pitfall: Immunohistochemical analysis of 100 cases

Applied Immunohistochemistry and Molecular Morphology

Volumn 4, Issue 3, 1996, Pages 167-175

  Guillou, Louis ^a   Wadden, Catherine ^c   Kraus, Madeleine D ^c   Dei Tos, Angelo P ^b   Fletcher, Christopher D M ^c  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b Treviso General Hospital   (Italy)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Malignant peripheral nerve sheath tumor; S 100 protein; Spindle cell sarcoma; Synovial sarcoma

Indexed keywords

PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NERVE SHEATH TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SPINDLE CELL; SYNOVIAL SARCOMA;

EID: 0029800650     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995;37:417-29.
2. Donato R. Perspectives in S-100 protein biology. Cell Calcium 1991;12:713-26.
3. Moore B. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739-744.
4. Weiss SW, Langloss JM, Enzinger FM. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest 1983;49:299-308.
5. Takahashi K, Isobe T, Ohtsuki Y, Akagi T, Sonobe H, Okuyama T. Immunohistochemical study on the distribution of α and β subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch B Cell Pathol 1984;45:385-96.
6. Kahn H, Marks A, Thom H, Baumal R. Role of antibody to S-100 protein in diagnostic pathology. Am J Pathol 1983;79: 341-7.
7. Nakajima T, Kameya T, Watanabe S, Hirota T, Sato Y, Shimosato Y. An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol 1982;6:715-27.
8. Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S100-α and S100-β proteins in normal non-nervous human tissue. Lab Invest 1987;57:489-98.
9. Takahashi K, Isobe T, Ohtsuki Y, Sonobe H, Takeda I, Akagi T. Immunohistochemical localization and distribution of S-100 protein in the human lymphoreticular system. Am J Pathol 1984;116:497-503.
10. Rasmussen V, Larsen K. S-100 protein distribution in malignant mesotheliomas. Acta Pathol Microbiol Scand 1985; 93:199-201.
11. Cocchia D, Lauriola L, Stolfi VM, Tallini G, Michetti F. S-100 antigen labels neoplastic cells in liposarcoma and cartilaginous tumours. Virchows Arch A Pathol Anat Histol 1983;402:139-45.
12. Dei Tos AP, Wadden C, Fletcher CDM. S-100 protein staining in liposarcoma: its diagnostic utility in the high grade myxoid (round cell) variant. Appl Immunohistochem 1996; 4:95-100.
13. Coindre JM, de Mascarel A, Trojani M, de Mascarel I, Pages A. Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S-100 protein and cytokeratin. J Pathol 1988;155:127-32.
14. Enzinger FM, Weiss SW. Soft tissue tumors, 3rd ed., St Louis: Mosby, 1995:153-154.
15. Fisher C, Schofield JB. S-100 protein positive synovial sarcoma. Histopathology 1991;19:375-7.
16. Ordón̄ez NG, Mahfouz SM, Mackay B. Synovial sarcoma: an immunohistochemical and ultrastructural study. Hum Pathol 1990;21:733-49.
17. Schmidt D, Thum P, Harms D, Treuner J. Synovial sarcoma in children and adolescents. A report from the Kiel Pediatric Tumor Registry. Cancer 1991;67:1667-72.
18. Fetsch JF, Meis JM. Synovial sarcoma of the abdominal wall. Cancer 1993;72:469-77.
19. Lopes JM, Bjerkehagen B, Holm R, Bruland O, Sobrinho-Simōes M, Nesland JM. Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation: study of 49 primary tumours, recurrences and metastases. Pathol Res Pract 1994;190:168-77.
20. Hsu SM, Raine L, Fanger H. Use of avidin-biotine-peroxidase complexe (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
21. Renwick PJ, Reeves BR, Dal Cin P, et al. Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histological sub-classification of synovial sarcoma. Cytogenet Cell Genet 1995;70:58-63.
22. Schmidt D, Harms D. The applicability of immunohistochemistry in the diagnosis and differential diagnosis of malignant soft tissue tumors. A reevaluation based on the material of the Kiel Pediatric Tumor Registry. Klin Padiatr 1990;202:224-9.
23. Herrerra GA, Turbat-Herrera EA, Lott RI. S-100 protein expression by primary and metastatic adenocarcinomas. Am J Clin Pathol 1988;89:168-76.
24. Mori M, Ninomiya T, Okada Y, Tsukitani K. Myoepitheliomas and myoepithelial adenomas of salivary gland origin. Immunohistochemical evaluation of filament proteins, S-100 alpha and beta, glial fibrillary acid proteins, neuron-specific enolase, and lactoferrin. Pathol Res Pract 1989;184: 168-78.
25. Gaertner E, Zeren EH, Fleming MV, Colby TV, Travis WD. Biphasic synovial sarcomas arising in the pleural cavity. A clinicopathologic study of five cases. Am J Surg Pathol 1996;20:36-45.
26. Wick MR, Swanson PE, Scheithauer BW, Manivel JC. Malignant peripheral nerve sheath tumor: an immunohistochemical study of 62 cases. Am J Clin Pathol 1987;87:425-33.
27. Daimaru Y, Hashimoto H, Enjoji M. Malignant peripheral nerve sheath tumors (malignant schwannomas): an immunohistochemical study of 29 cases. Am J Surg Pathol 1985;9: 434-44.
28. Fisher C, Carter RL, Ramachandra S, Thomas DM. Peripheral nerve sheath differentiation in malignant soft tissue tumours: an ultrastructural and immunohistochemical study. Histopathology 1992;20:115-25.
29. Hirose T, Hasegawa T, Kudo E, Seki K, Sano T, Hizawa K. Malignant peripheral nerve sheath tumors: an immunohistochemical study in relation to ultrastructural features. Hum Pathol 1992;23:865-70.
30. Ducatman BS, Scheithauer BW. Malignant peripheral nerve sheath tumors with divergent differentiation. Cancer 1984; 54:1049-57.
31. Woodruff JM, Christensen WN. Glandular peripheral nerve sheath tumors. Cancer 1993;72:3618-28.
32. Fisher C. Synovial sarcoma: ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumours. Hum Pathol 1986;17:996-1008.
33. Lopes JM, Bjerkehagen B, Sobrinho-Simōes M, Nesland JM. The ultrastructural spectrum of synovial sarcomas: a study of the epithelial type differentiation of primary tumors, recurrences, and metastases. Ultrastruct Pathol 1993;17: 137-51.
34. Swanson PE, Dehner LP, Sirgi KE, Wick M. Cytokeratin immunoreactivity in malignant tumors of bone and soft tissue. A reappraisal of cytokeratin as a reliable marker in diagnostic immunohistochemistry. Appl Immunohistochem 1994;2:103-12.
35. Salisbury JR, Isaacson PG. Synovial sarcoma: an immunohistochemical study. J Pathol 1985;147:49-57.
36. Jorgensen LJ, Lyon H, Myhre-Jensen O, Nordentoft A, Sneppen O. Synovial sarcoma: an immunohistochemical study of the epithelial component. APMIS 1994;102:191-6.
37. Meis JM, Enzinger FM, Martz KL, Neal JA. Malignant peripheral nerve sheath tumors (malignant schwannomas) in children. Am J Surg Pathol 1992;16:694-707.
38. Swanson PE, Manivel JC, Wick MR. Immunoreactivity for Leu-7 in neurofibrosarcoma and other spindle cell sarcomas of soft tissue. Am J Pathol 1987;126:546-60.
39. MIC2 (CD99) in synovial sarcoma: a potential cause of diagnostic confusion. Appl Immunohistochem 1995;3:168-173.
40. Gray MH, Rosenberg AE, Dickersin GR, Bhan AK. Glial fibrillary acid protein and keratin expression by benign and malignant nerve sheath tumours. Hum Pathol 1989;20:1089-96.
41. Miettinen M. Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am J Pathol 1991;138:505-13.
42. Calonje E, Fletcher CDM. Immunohistochemistry and DNA flow cytometry in soft-tissue sarcomas. Hematol Oncol Clin North Am 1995;9:657-75.
43. Miettinen M. Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma. Arch Pathol Lab Med 1988;112:637-40.
44. Gown AM, Boyd HC, Chang Y, Ferguson M, Reichler B, Tippens D. Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. Am J Pathol 1988;132:223-32.
45. Swanson PE, Wick M. Clear cell sarcoma. An immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue. Arch Pathol Lab Med 1989;113:55-60.
46. Mooi WJ, Deenik W, Peterse JL, Hogendoorn PCW. Keratin immunoreactivity in melanoma of soft parts (clear cell sarcoma). Histopathology 1995;27:61-5.
47. Lucas DR, Nascimento AG, Sim FH. Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases. Am J Surg Pathol 1992;16:1197-204.
48. Hasegawa T, Hirose T, Hizawa K. Clear cell sarcoma. An immunohistochemical and ultrastructural study. Acta Pathol Jpn 1989;39:321-7.
49. Zucman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet 1993;4:341-5.
50. Christensen WN, Strong EW, Bain MS, Woodruff JM. Neuroendocrine differentiation in the glandular peripheral nerve sheath tumor. Pathologic distinction from the biphasic synovial sarcoma with glands. Am J Surg Pathol 1988;12:417-26.
51. Corson JM, Weiss LM, Banks-Schlegel SP, Pinkus GS. Keratin proteins and carcinoembryonic antigen in synovial sarcomas: an immunohistochemical study of 24 cases. Hum Pathol 1984;15:615-21.